Crystal structure and Hirshfeld surface of 5-bromo­salicylic acid di­methyl­formamide mono­solvate

The asymmetric unit of the title compound comprises two mol­ecules of 5-bromo­salicylic acid and two mol­ecules of N,N-di­methyl­formamide (DMF). The crystal structure is dominated by strong O—H⋯O hydrogen bonds between the carb­oxy­lic acid groups of the 5-bromo­salicylic acid molecules and the carbonyl oxygen atoms of the DMF mol­ecules, with the solvent acting as a hydrogen-bond acceptor. This inter­action prevents the formation of the common carb­oxy­lic acid dimer observed in many benzoic acid derivatives.

Synthesis, crystal structure and Hirshfeld surface analysis of 3-[5-(4-chloro­phen­yl)-2-sulfanyl­idene-1,3,4-oxa­diazol-3-yl]-3-(4-methyl­phen­yl)-1-(thio­phen-2-yl)propan-1-one

The asymmetric unit of the title mol­ecule contains a planar oxa­diazole, a thio­phene and two phenyl rings. In the crystal, π–π stacking inter­actions and C—H⋯π(ring) inter­actions help to consolidate the packing.

Synthesis, crystal structure determination, Hirshfeld surface and crystal void analyses, inter­action energy calculations and energy frameworks of N-(2-methyl­phen­yl)-N′-pivaloyl­thio­urea

The asymmetric unit of the title compound comprises an ordered mol­ecule, consisting of methyl­phenyl and pivaloyl moieties attached to the N atoms of the central thio­urea entity.

Synthesis, crystal structure and Hirshfeld surface analysis of 2-(ethyl­sulfan­yl)-3-(2-methyl­prop­yl)-5,5-di­phenyl-4,5-di­hydro-3H-imidazol-4-one

In the title mol­ecule, the imidazolone ring is essentially planar and the inclinations of the planes of the two attached phenyl groups to its plane are distinctly different. There is a degree of π-delocalization in the ring about the tertiary nitro­gen which involves its lone pair. Directed inter­molecular inter­actions comprise C—H⋯O hydrogen bonds and two sets of C—H⋯π(ring) inter­actions. A Hirshfeld surface analysis was performed.

Synthesis and structure of ethyl 2,2-di­methyl-3-(naphthalen-1-yl)-1,2-di­hydro­benzo[c]siline-4-carboxyl­ate

In the title compound, C₂₄H₂₄O₂Si, the ethyl ester substituent shows two-site disorder and C—H⋯O contacts generate zigzag ribbons extending along [010].

Synthesis, structure and computational study of di­acetato­bis­(2-amino-6-fluoro-1,3-benzo­thia­zole-κN³)zinc(II)

The title tetra­hedral Zn^II complex with 2-amino-6-fluoro-1,3-benzo­thia­zole has been structurally characterized. The crystal packing is consolidated by N—H⋯O, bifurcated N—H⋯(O,F), C—H⋯π, O⋯π and offset π–π inter­actions.

Synthesis and structure of di­chlorido­{(E)-4-methyl-N′-[1-(pyridin-2-yl)ethyl­idene]benzohydrazide}zinc(II)

The ligand in the title complex was obtained by a condensation reaction between p-tolyl hydrazide and 2-acetyl­pyridine. The ligand mol­ecule bonds to the metal ion in a tridentate manner via its imino nitro­gen atom, its carbonyl oxygen atom, and the nitro­gen atom of the pyridine ring. In the extended structure, pairwise N—H⋯Cl hydrogen bonds generate inversion dimers and very weak C—H⋯Cl inter­actions link the dimers into sheets.

Byproduct identification: crystal structure of potassium 2-eth­oxy-2-oxo­acetate

The crystal structure of the title salt is made up from a potassium cation and a disordered 2-eth­oxy-2-oxo­acetate anion. The packing inter­actions are through electrostatic inter­actions between the potassium ions and the oxygen atoms.

Synthesis, crystal structure and Hirshfeld surface analysis of (Z)-2-({amino­[6-phenyl-3-(4-methylphen­yl)-1,2,4-triazin-5-yl]methyl­idene}amino)-6-meth­oxy­benzo[d]thia­zole-4,7-diyl di­acetate

In the crystal, mol­ecules are connected by inter­molecular N—H⋯O inter­actions and π–π inter­actions [centroid–to-centroid distance = 3.8200 (12) Å], forming ribbons along the b-axis direction.

Crystal structure of the pharmaceutical impurity 2-(4-chloro­benzo­yl)pyridine

The title compound is a pharmaceutical impurity and possible inter­mediate in the synthesis of carbinoxamine. The aromatic rings of the mol­ecule twist relative to one another resulting in an inter­planar angle of 38.1 (1)°. In the extended structure, the mol­ecules are packed into rippled sheets with offset face-to-face stacking of each aromatic ring with the equivalent ring in the neighboring mol­ecule.

Crystal structure of a hydrate of 1,3,5-substituted 2,4,6-tri­alkyl­benzene bearing hy­droxy­methyl and pyridinyl­amino groups

In the asymmetric unit, two mol­ecules of the 1,3,5-substituted 2,4,6-tri­alkyl­benzene and three water mol­ecules are connected by hydrogen bonds, forming well-defined complexes that constitute the smallest supra­molecular entities.

Crystal structure and Hirshfeld surface analysis of 2,5-di­methyl-1H-benzo[d]imidazole

The mol­ecule exhibits whole-mol­ecule disorder in a 0.849 (4)/0.151 (4) ratio. The bicyclic portion is planar. In the crystal, a layer structure is generated by N—H⋯N hydrogen bonds and C—H⋯π(ring) inter­actions.

Synthesis and crystal structure of N-benzyl-5,6-ep­oxy-7-oxabi­cyclo­[2.2.1]heptane-2,3-dicarboximide

The crystal structure of the title compound demonstrates a tetra­cyclic organic compound with defined stereochemistry. In the solid state, the compound organizes in a racemic chiral fashion with alternating N-benzyl units.

Crystal structures of new psychoactive substances 4-HO-DET and 4-AcO-DET

The solid-state structures of two synthetic psychoactive compounds that have recently appeared in products on the ‘magic mushroom' retail market are presented.

2,2′-(Ethane-1,2-di­yl)bis­[3-(pyridin-2-yl)imidazo[1,5-a]pyridin-2-ium] dichloride hexa­hydrate

The title compound crystallizes as a two-component twin in space group P2₁/n with Z′ = 1, exhibiting hydrogen-bonding corrugated layers of chloride ions and water mol­ecules that run approximately along the diagonal plane of the cell between columns of the stacked dications.

Zn(AsO₃)₂, a unique structure among arsenates with composition M^IIAs^V₂O₆

Zn(AsO₃)₂ is isotypic with the low-temperature modification of Zn(PO₃)₂ and consists of AsO₄ tetra­hedra condensed into polyarsenate chains with a periodicity of two tetra­hedra.

Crystal structure and Hirshfeld surface analysis of 1,2-bis­[5-(4-fluoro­phen­yl)-1,3-oxazol-2-yl]benzene

The title compound crystallizes in the monoclinic space group P2₁/c with one mol­ecule in the asymmetric unit. The two chemically equivalent substituents adopt different orientations relative to the central benzene ring. In the crystal, inversion-related mol­ecules form dimers through π–π stacking between oxazole rings and C—H⋯N hydrogen bonds. The dimers are further connected by C—H⋯N inter­actions into layers parallel to (100).

Structure of metaraminol hydrogen tartrate from synchrotron X-ray data and density functional theory calculations

The crystal structure of metaraminol hydrogen tartrate has been solved and refined using synchrotron X-ray powder diffraction data and optimized using density functional theory techniques.

Crystal structure and Hirshfeld surface analysis of aqua­(1,10-phenanthroline-κ²N,N′)bis­[3-(2-sulf­an­ylidene-2,3-di­hydro-1,3-benzoxazol-3-yl)propano­ato-κO]zinc(II) monohydrate

The crystal structure of a zinc(II) complex containing 3-(2-sulfanylidene-2,3-di­hydro-1,3-benzoxazol-3-yl)propano­ate and 1,10-phenanthroline ligands is described, together with its supra­molecular features and Hirshfeld surface analysis.

Structures of bimetallic Fe^III–Fe^III and trimetallic Fe^III–K–Fe^III complexes incorporating the deprotonated ligand N,N′-bis­(2-hy­droxy-3-meth­oxy­ben­zyl­idene)-1,2-phenyl­enedi­amine

The title compounds were formed from the reaction of the metallo-ligand [Fe^II(L)]·(H₂O) (H₂L is 2-{[2-(2-hy­droxy-3-meth­oxy­benzyl­idene­amino)­phenyl­imino]­meth­yl}-6-meth­oxy­phenol, C₂₂H₂₀N₂O₄) with yttrium acetate and potassium nitrate.

Inter­esting hurdles in the solution of pharmaceutical crystal structures using powder diffraction data

Although solving and refining a crystal structure using synchrotron powder diffraction data can be routine, many problems present features which make the process more difficult. These include difficulty in indexing, incorrect or approximate symmetry, and chemically-unreasonable models (poor conformations, incorrect compounds). Examples of each of these `inter­esting' features are provided, as well as the methods used for recognizing and overcoming them.